Cargando…
Atypical Neuroleptic Malignant Syndrome in a COVID-19 Intensive Care Unit
Neuroleptic malignant syndrome (NMS) has been defined as a life-threatening neurologic emergency related to the use of antipsychotic medications. It is most often seen with high-potency (first-generation) antipsychotic medications and may occur after a single dose. There have been conflicting report...
Autores principales: | Durbach, Joshua R, Rosen, Gerald, De La Cuesta, Carolina, Gottlieb, Seth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464418/ https://www.ncbi.nlm.nih.gov/pubmed/36110487 http://dx.doi.org/10.7759/cureus.27923 |
Ejemplares similares
-
Atypical Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
por: Grant, Heidi
Publicado: (2023) -
Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006) -
Clinical Profile and Outcome of Critically Ill COVID-19 Patients With Malignancy Admitted in Intensive Care Unit of a Tertiary COVID Center, India
por: Kumar, Rakesh, et al.
Publicado: (2021) -
Neuropsychiatric Outcomes in Intensive Care Unit Survivors
por: Joshi, Shivam, et al.
Publicado: (2023) -
An Overview of the Treatment Strategies of Extremities Ischemia in the Intensive Care Unit
por: Onur, Tuğba T, et al.
Publicado: (2023)